CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
about
Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinomaRegulation of PP2A by Sphingolipid Metabolism and SignalingCIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancerCancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers.Overexpression of CIP2A promotes bladder cancer progression by regulating EMT.Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.SET contributes to the epithelial-mesenchymal transition of pancreatic cancer.CIP2A expression predicts recurrences of tamoxifen-treated breast cancer.CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma.Oncoprotein CIP2A promotes the disassembly of primary cilia and inhibits glycolytic metabolism.
P2860
Q26739910-41C3A5E9-E308-4D76-82E3-3D6ABAFA9333Q27026038-FB928B03-B4C6-48B3-90B3-94535A4F6AEBQ27853345-951825CA-E723-42F7-B09F-DCFFF772D4F6Q33977247-E7326B43-933F-4412-B330-24B1CE8A96ABQ37428639-EFA60060-82D5-4774-8E08-E719243F41A4Q38228491-D55911C6-84C5-4553-A98A-7B6BABFF68C7Q38335027-72DE91CC-B97B-4BB2-A126-F0B05BED0291Q38846283-CDD61D69-8B7E-4A65-AAC0-6DB300F6616DQ38891984-EFC60146-308B-4945-AF6D-C82A6ABFBB8FQ38903935-FAC10B94-7FB4-4AE4-BA96-4A624DB71F59Q39028343-007B3BBB-8851-48D7-AF7E-F1BA79D1F497Q39098575-57E5A9D6-184B-4284-A572-CD1228266A52Q42100343-C5B66F29-FAA5-4DB6-9C38-25D7904831E5Q47649534-629BC55E-04A2-4B90-BE02-BB08354F10E4Q51158345-E60ADAF1-42CB-4237-8FA3-345532B55787Q52680870-D57CFD0B-4050-45FB-83B7-3086ECB7E792
P2860
CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@en
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@nl
type
label
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@en
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@nl
prefLabel
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@en
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
CIP2A expression is associated ...... creatic ductal adenocarcinoma.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-013-0775-2
P577
2013-04-09T00:00:00Z
P6179
1013312109